Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study

被引:47
|
作者
Schneider, Karolin [1 ]
Marbaix, Etienne [2 ,3 ]
Bouzin, Caroline [4 ]
Hamoir, Marc [5 ]
Mahy, Pierre [6 ]
Bol, Vanesa [1 ]
Gregoire, Vincent [1 ,7 ]
机构
[1] Catholic Univ Louvain, Ctr Mol Imaging Radiotherapy & Oncol MIRO, Inst Expt & Clin Res IREC, Brussels, Belgium
[2] St Luc Univ Hosp, Dept Pathol, Brussels, Belgium
[3] Catholic Univ Louvain, de Duve Inst, Cell Biol Unit, Brussels, Belgium
[4] Catholic Univ Louvain, Inst Expt & Clin Res IREC, IREC Imaging Platform, Brussels, Belgium
[5] St Luc Univ Hosp, King Albert II Canc Inst, Dept Otorhinolaryngol & Head & Neck Surg, Brussels, Belgium
[6] St Luc Univ Hosp, King Albert II Canc Inst, Dept Stomatol & Maxillofacial Surg, Brussels, Belgium
[7] St Luc Univ Hosp, King Albert II Canc Inst, Dept Radiat Oncol, Brussels, Belgium
关键词
HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; LYMPHOCYTES; PREVALENCE; PROGNOSIS; SURVIVAL; MARKERS; TUMORS;
D O I
10.1080/0284186X.2018.1445287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human papillomavirus (HPV) prevalence in oropharynx squamous cell carcinoma (OPSCC) is on the rise. HPV-linked OPSCCs represent a distinct clinical entity with a better treatment response and patient survival compared to tumors not linked to HPV. An emerging role in treatment response has been attributed to immune cell infiltration in human tumors. In this study, we investigated immune cell infiltration in human SCC of the head and neck region and its relation to overall survival after treatment with surgery (with or without radiotherapy) or concomitant chemo (or cetuximab)-radiotherapy. Materials and methods: Paraffin-embedded tumor samples of 136 patients with SCC of the larynx, hypopharynx, oral cavity and oropharynx were processed for immunohistochemical detection of CD3(+) T-cells, CD8(+) cytotoxic T-cells, CD20(+) B-cells and CD163(+) M2 macrophages within the tumor infiltrated area. Clinico-pathological data were analyzed as a function of tumor location and p16-status. Immune cell infiltration was represented as stained area on the whole tumor infiltrated area, compared for the different tumor locations and correlated to patient survival. Results: Patients with oropharynx tumors expressing significant p16 levels (p16-sg) had a 5-year overall survival of 85% compared to 43% for patients with no significant p16 (p16-ns) expression (HR: 0.3 - 95% CI: 0.1-0.6). Median immune cell infiltration (T- and B-lymphocytes) was significantly elevated in p16-sg oropharyngeal tumors, compared to p16-ns oropharyngeal tumors and to all other head and neck tumor locations. No difference in CD163(+) macrophage infiltration was observed across the different patient groups. In the whole population, a high infiltration by CD3(+) T-lymphocytes was associated to a significantly (p=.03; HR: 0.6, 95% CI: 0.4-0.97) better overall survival. Conclusion: Oropharynx cancer with significant p16 expression showed an increased overall survival and elevated T- and B-lymphocyte infiltration, which suggests a prognostic relevance of immune cell infiltration.
引用
收藏
页码:1165 / 1172
页数:8
相关论文
共 50 条
  • [41] Tumor suppressor ACER1 correlates with prognosis and Immune Infiltration in head and neck squamous cell carcinoma
    Liu, Zhixin
    Yang, Xiaoqi
    Chen, Shuai
    Jia, Wenming
    Qian, Ye
    Zhang, Minfa
    Fang, Tianhe
    Liu, Heng
    Yang, Hui
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites
    Wondergem, Niels E.
    Nauta, Irene H.
    Muijlwijk, Tara
    Leemans, C. Rene
    van de Ven, Rieneke
    CURRENT ONCOLOGY REPORTS, 2020, 22 (08)
  • [43] Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation
    Feng, Yao
    Zhou, Ying-Hui
    Zhao, Jie
    Su, Xiao-Lin
    Chen, Ning-Xin
    Zhao, Ya-Qiong
    Ye, Qin
    Hu, Jing
    Ou-Yang, Ze-Yue
    Zhong, Meng-Mei
    Yang, Yi-Fan
    Han, Peng-Ju
    Guo, Yue
    Feng, Yun-Zhi
    FRONTIERS IN GENETICS, 2023, 14
  • [44] The role of autophagy in squamous cell carcinoma of the head and neck
    Cosway, Benjamin
    Lovat, Penny
    ORAL ONCOLOGY, 2016, 54 : 1 - 6
  • [45] Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma
    Almokadem, Salah
    CURRENT MOLECULAR PHARMACOLOGY, 2016, 9 (03) : 226 - 230
  • [46] Head and neck squamous cell carcinoma in young patients
    van Monsjou, Hester S.
    Wreesmann, Volkert B.
    van den Brekel, Michiel W. M.
    Balm, Alfons J. M.
    ORAL ONCOLOGY, 2013, 49 (12) : 1097 - 1102
  • [47] Genetic Susceptibility to Head and Neck Squamous Cell Carcinoma
    Lacko, Martin
    Braakhuis, Boudewijn J. M.
    Sturgis, Erich M.
    Boedeker, Carsten C.
    Suarez, Carlos
    Rinaldo, Alessandra
    Ferlito, Alfio
    Takes, Robert P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (01): : 38 - 48
  • [48] Clinical Outcome of Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Won, Hye Sung
    Lee, Youn Soo
    Jeon, Eun Kyoung
    Hong, Sook Hee
    Kang, Jin-Hyoung
    Kim, Yeon-Sil
    Yoo, Le Ryung
    Sun, Dong-Il
    Kim, Min-Sik
    ANTICANCER RESEARCH, 2014, 34 (10) : 5709 - 5714
  • [49] Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
    Elmusrati, Areeg
    Wang, Justin
    Wang, Cun-Yu
    INTERNATIONAL JOURNAL OF ORAL SCIENCE, 2021, 13 (01)
  • [50] Oral health and risk for head and neck squamous cell carcinoma: the Carolina Head and Neck Cancer Study
    Divaris, Kimon
    Olshan, Andrew F.
    Smith, Joanna
    Bell, Mary E.
    Weissler, Mark C.
    Funkhouser, William K.
    Bradshaw, Patrick T.
    CANCER CAUSES & CONTROL, 2010, 21 (04) : 567 - 575